Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Tenaya Therapeutics $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Colfax $287.3 million secondary offering
We advised certain selling stockholders on the transaction
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
Natera $584.8 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
Royalty Pharma $1.3 billion senior notes offering
We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
TScan Therapeutics $100 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Acutus Medical $77 million follow-on offering
We advised Acutus Medical on the SEC-registered stock offering
Sight Sciences $276 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
IVERIC bio $115.2 million stock offering
We advised the underwriters on the SEC-registered equity offering
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing